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Research
The adverse effects of low-level developmental
lead exposure [blood lead (BPb) ≤ 10 µg/dL]
on cognitive, auditory, and visual-motor
function are well documented (Canﬁeld et al.
2003; Osman et al. 1999; Rothenberg et al.
2000; Wasserman et al. 2000), but only two
studies have examined the impact of low-
level developmental Pb exposure on retinal
and visual function in children (Altmann
et al. 1998; Rothenberg et al. 2002). This
lack of research is despite ﬁndings that retinal
and visual cortical structural–functional
abnormalities occur in animals after moder-
ate-level (BPb 11–39 µg/dL) and high-level
(BPb ≥ 40 µg/dL) developmental Pb expo-
sure (reviewed by Fox and Boyes 2007; Otto
and Fox 1993).
Persistent rod photoreceptor-mediated
(scotopic) electroretinographic (ERG) and
behavioral deﬁcits occur in monkeys, rats, and
mice after moderate-level and high-level post-
natal Pb exposure (PLE) (Fox and Boyes
2007). The scotopic ERG alterations are char-
acterized by decreases in a-wave and b-wave
ERG amplitude (subnormality), sensitivity,
and temporal resolution. Similar ERG
changes occurred in Pb-exposed workers and
isolated retinas exposed to Pb2+ (Otto and Fox
1993). In contrast, adult monkeys with high-
level lifetime Pb exposure exhibited increased
ERG b-wave amplitudes (supernormality)
(Lilienthal et al. 1994). Moreover, our
prospective epidemiologic study of children
with lifetime low-level and moderate-level Pb
exposure revealed that only gestational Pb
exposure (GLE) showed a significant dose-
dependent relationship with supernormal
ERG a-waves and b-waves and increased
b-wave sensitivity with no change in implicit
times (Rothenberg et al. 2002).
In experimental animals, supernormal
scotopic ERGs are observed after the loss of
retinal dopamine (DA) or zinc. For example,
the destruction of dopaminergic amacrine
cells by the neurotoxin 6-hydroxydopamine
produced supernormal scotopic ERGs with
normal implicit times (Olivier et al. 1986;
Skrandies and Wässle 1988). Similarly, ani-
mals administered nonselective dopamine
receptor antagonists had supernormal scotopic 
b-waves with normal implicit times (Jagadeesh
et al. 1980; Schneider and Zrenner 1991). A
persistent decrease in retinal tyrosine hydrox-
ylase immunoreactivity after lifetime Pb
exposure in monkeys suggests that a loss of
DA produced supernormal ERGs (Kohler
et al. 1997; Lilienthal et al. 1994). Chelation
of retinal Zn produced supernormal scotopic
ERGs and increased b-wave sensitivity
(Redenti and Chappell 2003). Although no
published reports have shown that scotopic
ERG supernormality results from an increased
number of rods, the log scotopic b-wave
threshold and amplitude are linearly related
to the number of rod photoreceptors and
their rhodopsin content per eye (Dowling
1960). Therefore, we hypothesized that GLE
produced supernormal scotopic ERGs by
one of these three relatively independent
mechanisms: an increased number of rod
photoreceptors, decreased retinal DA
metabolism, and/or decreased retinal Zn
concentrations.
To determine the sites and mechanisms
of the GLE-induced supernormal scotopic
ERGs, we developed a new dose–response
model of GLE. Then, we conducted scotopic
ERG studies and retinal histologic, morpho-
metric, and neurochemical experiments in
adult offspring. Low-level and moderate-level
GLE produced supernormal scotopic ERGs,
an increased neurogenesis of rods and rod
bipolar cells (BCs), and decreased DA synthe-
sis and utilization/release in the absence of
retinal injury. GLE produced inverted
U-shaped dose–response curves as the high-
level GLE dose produced rod cell loss and
thus ERG subnormality.
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BACKGROUND: Postnatal lead exposure in children and animals produces alterations in the visual
system primarily characterized by decreases in the rod-mediated (scotopic) electroretinogram (ERG)
amplitude (subnormality). In contrast, low-level gestational Pb exposure (GLE) increases the ampli-
tude of scotopic ERGs in children (supernormality).
OBJECTIVES: The goal of this study was to establish a rat model of human equivalent GLE and to
determine dose–response effects on scotopic ERGs and on retinal morphology, biochemistry, and
dopamine metabolism in adult offspring.
METHODS: We exposed female Long-Evans hooded rats to water containing 0, 27 (low), 55 (moder-
ate), or 109 (high) ppm of Pb beginning 2 weeks before mating, throughout gestation, and until
postnatal day (PND) 10. We measured maternal and litter indices, blood Pb concentrations (BPb),
retinal Pb concentrations, zinc concentrations, and body weights. On PND90, we performed the
retinal experiments.
RESULTS: Peak BPb concentrations were < 1, 12, 24, and 46 µg/dL in control, low-, moderate- and
high-level GLE groups, respectively, at PNDs 0–10. ERG supernormality and an increased rod
photoreceptor and rod bipolar cell neurogenesis occurred with low- and moderate-level GLE. In
contrast, high-level GLE produced ERG subnormality, rod cell loss, and decreased retinal Zn levels.
GLE produced dose-dependent decreases in dopamine and its utilization.
CONCLUSIONS: Low- and moderate-level GLE produced persistent scotopic ERG supernormality
due to an increased neurogenesis of cells in the rod signaling pathway and/or decreased dopamine
utilization, whereas high-level GLE produced rod-selective toxicity characterized by ERG subnor-
mality. The ERG is a differential and noninvasive biomarker of GLE. The inverted U-shaped
dose–response curves reveal the sensitivity and vulnerability of the developing retina to GLE.
KEY WORDS: bipolar cells, development, dopamine, electroretinograms, gestation, lead, neuro-
genesis, rod photoreceptors, scotopic, zinc. Environ Health Perspect 116:618–625 (2008).
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Animals. All experimental and animal care
procedures complied with the National
Institutes of Health (NIH)/Public Health
Service Policy on the Humane Care and Use
of Laboratory Animals (NIH 2002) and were
approved by the Institutional Animal Care
and Use Committee of the University of
Houston. All animals were treated humanely
and with regard for alleviation of suffering.
Adult (55–60 days of age) female and male
Long-Evans hooded rats were obtained from
Harlan Sprague Dawley, Inc. (Indianapolis,
IN). The animals were housed in a room with
a 12:12 hr light:dark cycle as described previ-
ously (Fox and Farber 1988).
We used two animal models: GLE and
PLE. For each, dams were mated with a single
male overnight, and the presence of a vaginal
plug was recorded as gestational day 0.5.
Control males were used once for breeding
with Pb-exposed dams. Dams were weighed
twice weekly until postnatal day (PND) 21
(weaning). On the day of birth (PND0), we
recorded the number of pups, and sex and
weight of the offspring (12–15 litters per
group). On PND1, litters were culled to eight
pups each. Only female rats were used to
directly compare the present results with our
previous ERG and retinal morphology studies
conducted with adult female rats after PLE
(reviewed by Fox and Boyes 2007). Pups were
weighed on PNDs 7, 10, and 21. At weaning,
rats were housed four per cage and weighed
monthly. We performed ERG, morphologic,
and neurochemical experiments at PND90.
Protein values were obtained using the
Bradford assay (Bradford 1976). For all ana-
lytical experiments, rats were decapitated
1–2 hr after light onset.
GLE model. Two weeks after arrival,
female rats were singly housed and randomly
divided into four groups: one control group
and three GLE groups. Control dams received
water, and GLE dams received one of three Pb
acetate drinking solutions (Fisher Scientific,
Pittsburgh, PA): 0.005% (27 ppm Pb: low-
level GLE), 0.01% (55 ppm Pb: moderate-
level GLE), or 0.02% (109 ppm Pb: high-level
GLE). Lead drinking solutions were provided
to dams 2 weeks before mating to ensure BPb
concentration stabilization and a Pb body bur-
den, throughout gestation and until PND10.
We selected the prenatal through PND10
period (Figure 1) because rodent brain and
retinal development during this period is
equivalent to that during human gestation
(Dobbing and Sands 1979; Raedler and
Sievers 1975; Rice and Barone 2000).
PLE model. The details of this model are
presented to distinguish the BPb concentra-
tion proﬁles and kinetics from those in GLE
rats. Four weeks after arrival, female rats were
singly housed and randomly divided into four
experimental groups: one control and three
PLE groups. Upon delivery and throughout
lactation (PNDs 0–21), PLE dams received
0.005% (low-level PLE), 0.01% (moderate-
level PLE), or a 0.02% (high-level PLE) Pb
acetate drinking solution as previously
described (Fox et al. 1991).
Blood and retinal Pb, and retinal Zn
concentrations. After decapitating the rats, we
measured trunk BPb concentrations in GLE
dams after 14 days of Pb pretreatment and on
PND0. We measured trunk BPb concentra-
tions in GLE offspring at PNDs 0, 10, 21, 30,
and 90 and in PLE offspring at PNDs 10, 21,
45, 60, and 90. BPb concentrations, expressed
as micrograms per deciliter, were measured by
anodic stripping voltammetry using the
LeadCare Kit1 (sensitivity: ≤ 1 µg/dL;
Environmental Sciences Associates, Inc.,
Chelmsford, MA). Retinal Pb concentrations
and Zn concentrations, expressed as parts per
million (micrograms per gram wet weight),
were measured in GLE offspring at PNDs 0,
10, 30, and 90 by anodic stripping voltam-
metry or by atomic absorption spectrometry as
previously described (Fox and Farber 1988).
Values are reported for six to nine rats or ﬁve
to seven retinas per age per group.
Scotopic ERG procedures and analysis.
ERG experiments were performed essentially
as described by Fox and Farber (1988). We
performed all procedures on dark-adapted
rats under dim red illumination (λ > 650 nm).
Rats were anesthetized with urethane
(1.7 mg/kg, intraperitoneal injection), posi-
tioned in a Kopf stereotaxic apparatus, and
placed on a heating pad that maintained core
temperature at 37.0 ± 0.5°C. The left eye was
covered with an occluder. The right cornea was
anesthetized with 0.5% proparacaine hydro-
chloride, and the pupil was dilated with 1%
atropine and 2.5% phenylephrine. A circular
platinum–iridium recording electrode was
positioned around the pupil, and platinum–
iridium reference and ground electrodes were
placed on the ear and tongue, respectively.
Rats were then dark-adapted for 2 hr before
ERG recordings.
Light stimulation was provided by a
300-watt quartz-iodine lamp through a
Maxwellian optical system. The light was
projected through a fiber optic cable that
focused at the pupil and subtended 60° on the
retina. Flash duration was 10 msec. ERG sig-
nals were amplified and filtered (bandwidth
0.1 Hz–1 KHz), displayed and monitored on
an oscilloscope, and stored and analyzed on a
computer. We recorded single-flash scotopic
ERGs over a 7 log unit range of intensity
[–4.5 to +2.5 log candela-seconds per square
meter (cd-sec/m2)] in seven control rats.
In fully dark-adapted mammalian retinas,
the single-photon rod signal is sequentially
transmitted to depolarizing rod BCs, AII
glycinergic amacrine cells, on and off cone
BCs, on and off ganglion cells, and then to
central visual centers (Bloomfield and
Dacheux 2001). Rat rod BCs receive input
from 16–25 rods (Greferath et al. 1990). The
peak a-wave mostly reﬂects rod photocurrents
but can have postreceptoral contributions
(Robson et al. 2003), whereas the rat a-wave
amplitude at 8 (Bui and Fortune 2004) or
10 msec (Mojumder and Frishman, personal
communication) reflects rod photoreceptor
function. We measured the negative-going
a-wave amplitude at 10 msec after the flash
and from baseline to its peak response. The
peak of the positive-going b-wave amplitude,
which reﬂects currents from depolarizing rod
BCs and with additional BC-dependent K+
currents that affect Müller glial cells (Robson
and Frishman 1999), was measured from the
peak a-wave to peak b-wave, or in the absence
of an a-wave from the baseline to its peak. We
measured a-wave and b-wave peak implicit
times. We fit b-wave amplitude data by the
Michaelis-Menton equation using an iterative
procedure that minimized the mean square
error to ≤ 0.1%; flash intensities for b-wave
half-saturation and maximal amplitude values
were then determined (Rothenberg et al.
2002). Based on well-validated scotopic ERG
testing procedures (Dalke et al. 2004), we
used the ﬂash intensities for the b-wave half-
saturation value and maximal amplitude value
as test stimulus 1 (low intensity) and test
stimulus 2 (high intensity) to assess the effects
of GLE on the scotopic ERG (n = 5–7 rats
per GLE group).
Epiﬂuorescent and morphometric retinal
studies. Rats were decapitated, and their eyes
were rapidly removed and immersed in ice-
cold phosphate-buffered saline (PBS), and the
corneas were gently punctured. The eyes were
immersion-fixed in 4% buffered para-
formaldehyde for 30 min for epifluorescent
studies or Karnovsky’s mixed-aldehyde ﬁxative
for 12 hr at 4°C for light microscopy as
described previously (Fox and Chu 1988; He
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Figure 1. Rat model for human equivalent GLE.
Female rats were exposed to Pb for 14 days before
conception [embryonic day 0 (E0)] to establish
steady-state BPb levels before mating. After mat-
ing, dams were exposed to Pb throughout gesta-
tion, and exposure was continued from birth
(PND0) until PND10. This GLE model ensures that
offspring were exposed for a period equivalent to
the duration of human gestation. Experiments were
conducted using adult (PND90) rats.
Pb exposure
Gestational development
E0 PND0 PND10 PND21 PND90
2 weeks 3 weeks
Start
Pb
Mating Stop
Pb
Birth Weaning ERG, histology,
metal analysis, and
neurochemistryet al. 2000). For each experiment, we used ﬁve
to seven retinas per GLE group.
For epiﬂuorescent studies, ﬁxed eyes were
rinsed in PBS and cryoprotected. Anterior seg-
ments were removed, and eyecups were
embedded in tissue-freezing medium and
frozen in liquid nitrogen. Frozen retinas
were sectioned along the vertical meridian
(10–15 µm), collected on slides, and stored at
–20°C. Sections were obtained from superior
central retina (200–400 µm from the optic
nerve head), labeled with the monoclonal
mouse anti-protein kinase C (PKC)αβ clone
MC5 antibody (BD Biosciences Pharmingen,
San Jose, CA) that selectively stains rat rod
BCs (Greferath et al. 1990; Osborne et al.
1992), and stained with AlexaFluor488-conju-
gated secondary antibody (Molecular Probes,
Eugene, OR) or DAPI (4´,6-diamidino-2-
phenylindole). We visualized and pho-
tographed retinas on an Olympus IX70
microscope (Olympus, Center Valley, PA) as
previously described (Greferath et al. 1990; He
et al. 2000).
We obtained counts of rod and cone
photoreceptor cells (nuclei) in central and
peripheral sections of the superior and inferior
temporal retina of GLE rats from plastic sec-
tions (1–1.2 µm) stained with toluidine blue
as described previously (Fox and Chu 1988;
He et al. 2003). Nuclei counts were made
from slides using a calibrated Filar micrometer
eyepiece (Reichert Scientific Instruments,
Buffalo, NY). We examined 20 fields, each
100 µm in length, in 3 sections per retina.
Values are presented as rod and cone nuclei
per 100 µm of retina because there were no
significant differences between superior or
inferior retina.
The outer nuclear layer (ONL), inner
nuclear layer (INL), and total retinal thickness
were measured from the same retinas (Fox and
Rubinstein 1989). A change in retinal layer
thickness reflects changes in cell number
(Unoki and LaVail 1994). The ONL contains
rods and cones, whereas the INL contains
BCs, amacrine cells, horizontal cells, and
Müller glial cells. We measured retinal layer
and total retinal thickness in central superior
and inferior retina with a Filar micrometer
eyepiece 500 µm from the optic nerve head.
Three repeat measures were obtained for each
retina. Values for each GLE group are pre-
sented as retinal layer and total retinal thick-
ness (micrometers) because there were no
significant differences between superior or
inferior retina.
Rhodopsin measurements. GLE rats, dark-
adapted overnight, were decapitated and the
concentration of rhodopsin per eye was deter-
mined as described (Fox and Rubinstein
1989). The entire dark-adapted procedure was
carried out under dim red light (λ > 650 nm).
Visual pigment was extracted from two excised
neuroretinas per rat with Emulphogene
BC-720 (Gaf Corp., Wayne, NJ), and pre-
bleach and postbleach scans were obtained
from 350 to 700 nm with a Hewlett-Packard
8472A UV-VIS spectrophotometer (Hewlett-
Packard, Palo Alto, CA). We obtained the
absorbances of rhodopsin at its λmaximum
(497–500 nm) from difference spectra. Values
are for ﬁve or six rats per GLE treatment group
and are expressed as nanomoles per eye.
Glial fibrillary acidic protein measure-
ments. Glial ﬁbrillary acidic protein (GFAP),
the principal intermediate ﬁlament protein of
glial cells, is a quantitative marker of glia;
increased expression of GFAP is a marker of
neuronal/glial damage or gliosis (O’Callaghan
and Sriram 2005). We isolated and cleaned two
retinas from each rat and determined retinal
GFAP concentrations using the ELISA sand-
wich technique as described by O’Callaghan
and Sriram (2005). Values are for three to ﬁve
rats per GLE treatment group and are expressed
as nanograms GFAP per milligram protein.
Western blot analysis. To determine the
concentration of PKCαβ and thereby the rela-
tive number of rod BCs, we conducted
Western blotting experiments using the mono-
clonal mouse anti-PKCαβ clone MC5 anti-
body essentially as described previously (He
et al. 2000; Osborne et al. 1992). Two retinas
from each rat were isolated, cleaned in ice-cold
PBS, and frozen at –80°C. Thawed retinas
were homogenized in lysis buffer and cen-
trifuged, and 20–30 µg protein was loaded
onto a SDS-PAGE gel. Gels were stained with
MC5 primary antibody and a goat anti-mouse
IgG secondary antibody conjugated to horse-
radish peroxidase (Jackson ImmunoResearch
Laboratories, West Grove, PA), and visualized
using an ECL Plus kit (Amersham Biosciences,
Piscataway, NJ). We used a rabbit polyclonal
GAPDH conjugated to horseradish peroxidase
(ab9385; Abcam, Cambridge, MA), which
yielded a 38-kDa band, as a loading control.
We quantified the intensities of the bands
using NIH Image 1.62 software. Values are for
three to ﬁve rats per GLE treatment group.
HPLC studies. Retinas were rapidly
removed, cleaned, placed in ice-cold 0.2 N
perchloric acid, and frozen at –80°C. Frozen
samples were homogenized and centrifuged at
4°C. We measured concentrations of retinal
DA, dihydroxyphenylacetic acid (DOPAC),
and homovanillic acid (HVA) in the super-
natant with an ESA HPLC-electrochemical
detector system (ESA, Bedford, MA) (Kala and
Jadhav 1995). Values are for ﬁve to six rats per
GLE treatment group and are expressed as
nanograms per milligram protein. We used
DOPAC/DA and HVA/DA concentration
ratios as measures of DA utilization and release
(Boireau et al. 1990).
Statistical analysis. Only one animal per
litter or one retina per animal was used for
any measure. We analyzed group data by a
one-way analysis of variance (ANOVA), with
or without repeated measures, followed by
post hoc multiple comparisons using Tukey’s
honestly significant difference test when sig-
nificant main effects of Pb were found
(KaleidaGraph; Synergy Software, Reading,
PA). Data are presented as mean ± SE, and
the difference from controls is regarded as
signiﬁcant if p < 0.05.
Results
Animal models and BPb, retinal Pb, and Zn
levels. We measured fluid consumption and
Fox et al.
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Table 1. Maternal and litter measures for control Long-Evans hooded rats.
Measure Outcome results
Maternal
Dams’ daily mean ﬂuid consumption (mL/day)
For 14 days before mating  14.7 ± 0.8
During gestation 29.5 ± 1.8
PND1–PND10 46.8 ± 3.7
Dams’ weight (g)
14 days before mating 223 ± 6
At mating 247 ± 7
Total weight gain during pregnancy 127 ± 6
Mating success rate (%) 93.8 ± 1.2
Litter and physical milestones
Length of gestation (days) 20.5 ± 0.2
Mean litter size (pups) 11.9 ± 0.4
Sex distribution at birth [male/female (%)] 54/46
Litter mortality (dead newborn pups/litter) 0.2 ± 0.1
Pup mortality during lactation (%) 1.9 ± 0.1
Eye opening [male/female (%)]
At PND14, one or both eyes 78 ± 5/75 ± 6
At PND16, both eyes 100/100
Female offspring body weight (g)
At birth (PND0)  6.12 ± 0.14
PND10 20.3 ± 1.2
PND21 50.1 ± 2.1
PND90 254.6 ± 4.8
Mean ± SE values are from 12–15 control dams and litters.body weight of dams exposed to water or Pb
from 14 days before conception until birth, and
we recorded gestational and litter measures/
milestones. Control values (Table 1) were simi-
lar to those previously reported for Long-Evans
hooded rats (Church et al. 1990; Newland and
Reile 1999). We found no signiﬁcant differ-
ences between groups on any maternal or litter
measure/milestone (data not shown). Table 1
presents the body weights of control rats at
PNDs 0, 10, 21, and 90. There were no signif-
icant effects of GLE on body weight at any age
(data not shown).
Figure 2A shows that control, low-level,
moderate-level, and high-level GLE produced
concentration-dependent increases in BPb
concentrations at PNDs 0–10 with peak BPb
concentrations of 1, 10–12, 21–24, and
40–46 µg/dL, respectively. By PND30, the
BPb level in GLE rats was not signiﬁcantly dif-
ferent from controls. Figure 2B shows that con-
trol, low-level, moderate-level, and high-level
PLE produced signiﬁcant concentration-depen-
dent increases in BPb levels from PND10 to
PND21, with peak BPb concentrations of 1,
11, 21, and 26 µg/dL, respectively, and that
BPb concentrations were still signiﬁcantly ele-
vated at PND45 and PND60. By PND90, the
BPb level in PLE rats was not signiﬁcantly dif-
ferent from controls (data not shown) (Fox
et al. 1991). Retinal Pb concentrations mir-
rored those of BPb for all GLE groups
(Figure 2C) and PLE groups (Fox and Farber
1988; Fox et al. 1991; data not shown). Except
for the high-level GLE, retinal Zn concentra-
tion was not signiﬁcantly changed (Figure 2D).
Single-ﬂash scotopic ERGs. Representative
single-flash ERGs from fully dark-adapted
adult control and GLE rats are illustrated in
Figure 3A. The a-wave and b-wave voltage-log
intensity curves for control rats (Figure 3B)
show that the b-wave reached its maximum
amplitude and plateaued at 2.5 log cd-sec/m2,
whereas the a-wave had not plateaued. We
used this stimulus intensity as test stimulus 2
(high intensity) in our ERG protocol. The
stimulus intensity for the b-wave half-saturation
value was –0.5 log cd-sec/m2, which was used
as test stimulus 1 (low intensity) in our ERG
protocol (Figure 3B).
In controls, peak a-wave amplitude with the
low- and high-intensity stimuli were 141 ± 14
and 409 ± 19 µV, respectively (Figure 4A). The
peak a-wave amplitude increased signiﬁcantly
in the low-level GLE (12–16%) and moderate-
level GLE (22–26%) groups at both stimulus
intensities, whereas it decreased significantly
(11%) in the high-level GLE group at the high
intensity stimulus (Figure 4A). In controls,
a-wave amplitude at 10 msec was 79 µV ± 8.0
(Figure 4B). This increased signiﬁcantly (30%)
in the low-level and moderate-level GLE groups
(Figure 4B). In controls, peak b-wave ampli-
tude with the low- and high-intensity stimuli
were 670 ± 28 and 1,387 ± 41 µV, respectively
(Figure 4C). The peak b-wave amplitude
increased significantly in the low-level
(14–19%) and moderate-level (28–31%) GLE
groups at both stimulus intensities, whereas it
decreased signiﬁcantly (10%) in the high-level
GLE group at the high-intensity stimulus
(Figure 4C). The increased peak b-wave ampli-
tude at high stimulus intensity was signiﬁcantly
larger in the moderate-level than in the low-
level GLE group. The control peak a-wave and
b-wave latencies at the low (47.6 ± 4.1 and 92.2
± 7.9, respectively) and high (20.7 ± 1.7 and
68.6 ± 5.8, respectively) stimulus intensities
were not signiﬁcantly different compared with
those in the GLE groups.
Retinal morphometry. Representative
images of DAPI-stained adult GLE retinas
revealed that low-level and moderate-level
GLE increased ONL and INL thickness
(Figure 5). These increases reﬂect an increase
of one to three nuclei per retinal layer. In
controls, the ONL, INL, and total central
retinal thickness was 38.7 ± 3.0, 17.5 ± 1.6,
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Figure 3. Single-flash scotopic ERG waveforms of
adult control and GLE rats (A) and voltage-log inten-
sity plot of ERG a- and b-waves for controls (B).
(A) Single-ﬂash scotopic ERGs were recorded over
a 7 log unit range of intensity for controls and at a
high (2.5 log cd-sec/m2) and low (–0.5 log cd-sec/m2)
stimulus intensity in GLE rats. (B) Flash intensities for
the b-wave half-saturation value (test stimulus 1:
low intensity) and maximal amplitude value (test
stimulus 2: high intensity) were used to assess the
effects of GLE on scotopic ERGs.
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Figure 2. BPb, retinal Pb, and Zn concentrations. (A) BPb concentrations at PNDs 0, 10, and 21, but not PND30
were signiﬁcantly different in GLE from controls. (B) BPb concentrations at PNDs 10, 21, 45, and 60 were sig-
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signiﬁcantly different in GLE from controls. (D) Retinal Zn concentration at PND90 was signiﬁcantly different
in high-level GLE from controls.
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Age (PND) Age (PND)and 201.2 ± 2.1 µm, respectively (Figure 6A).
Low-level and moderate-level GLE signifi-
cantly increased ONL thickness (17–24%),
INL thickness (40–50%), and total retinal
thickness (10–16%), whereas high-level GLE
significantly decreased ONL thickness by
14% (Figure 6A). In control central and
peripheral retina, there were 137.8 ± 5.6 and
87.3 ± 4.3 rod nuclei per 100 µm, respec-
tively (Figure 6B), and 2.9 ± 0.3 and 1.7 ±
0.3 cone nuclei per 100 µm, respectively.
These values are consistent with our previous
results (Fox and Chu 1988). Low-level and
moderate-level GLE exhibited significant
dose-dependent increases in the number of
rods in central (16% and 35%, respectively)
and peripheral retina (18% and 38%, respec-
tively). In contrast, high-level GLE signifi-
cantly decreased the number of rods in central
and peripheral retina: 10% and 12%, respec-
tively (Figure 6B). The number of cones was
not changed signiﬁcantly by GLE treatment.
We measured the level of rhodopsin per
eye to determine whether the GLE-induced
changes in rod nuclei density corresponded to
a changed amount of the rod G-protein cou-
pled receptor. In controls, the rhodopsin per
eye was 1.97 ± 0.4 nmol (Figure 6B), consis-
tent with our previous results (Fox and
Rubinstein 1989). Low-level GLE (13%) and
moderate-level GLE (29%) exhibited signiﬁ-
cant dose-dependent increases in rhodopsin
concentration per eye, whereas it decreased
significantly (12%) in high-level GLE rats
(Figure 6B).
Morphometric analysis showed that low-
level and moderate-level GLE increased INL
thickness (Figure 6A). Examination of the reti-
nas suggested that the number of BCs was
increased by GLE, consistent with our super-
normal b-wave results (Figure 4C). A control
retina immunostained for PKCαβ showed that
the entire rod BC selectively labeled with
PKCαβ (Figure 6C), as described by Greferath
et al. (1990). PKCαβ content significantly
increased in the low-level (21%) and moder-
ate-level (37%) GLE groups, consistent with
the increase in INL thickness (Figures 5
and 6A), and was not signiﬁcantly different in
the high-level GLE group (Figure 6C).
Retinal glial fibrillary acidic protein. In
control retinas, GFAP expression increased
from 5 ng/mg protein at PND10 to adult levels
(80–90 ng/mg protein) at PND21 (Figure 6D).
We found no signiﬁcant effects of GLE on this
measure at any age, indicating that there was
no change in the number of Müller glial cells
and no retinal injury.
Retinal dopamine metabolism. Figure 7A
shows that the dark-adapted and light-
adapted DA concentrations are similar in
controls: 6.02 ± 0.37 and 5.90 ± 0.33 ng/mg
protein, respectively. This occurs because
light activates tyrosine hydroxylase, the rate-
limiting step, to synthesize DA (Iuvone et al.
1978). In contrast, Figure 7A shows that low-
level, moderate-level, and high-level GLE pro-
duced signiﬁcant dose-dependent decreases in
dark-adapted DA (12, 19, and 27%) and light-
adapted DA (23, 31, and 43%). In controls,
the light-adapted compared to dark-adapted
levels of DOPAC increased 86% (Figure 7B).
Low-level, moderate-level, and high-level GLE
produced signiﬁcant dose-dependent decreases
in dark-adapted DOPAC (10, 16, and 32%)
and light-adapted DOPAC (39, 40, and 55%)
(Figure 7B). Similar dose-dependent GLE
effects were observed for HVA, the other
major DA metabolite (Figure 7C). The GLE-
induced decreases in DA, DOPAC, and HVA
concentrations were signiﬁcantly larger in the
light, suggesting that GLE inhibited tyrosine
hydroxylase and/or caused a loss of DA
amacrine cells. Moreover, these GLE-induced
changes in light-adapted DA metabolism
resulted in dose-dependent decreases in DA
utilization/release for DOPAC/DA and
HVA/DA concentrations: 13–18% and
22–25%, respectively (Figure 7D).
Discussion
In the present study, we obtained five novel
results. First, we established a new and clini-
cally relevant rat model of human equiva-
lent GLE, an exposure period of increasing
relevance and concern (Landrigan et al. 2005;
Fox et al.
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Figure 4. a-Wave and b-wave ERG amplitudes in adult control and GLE rats. (A) Relative to controls, peak ERG a-wave amplitude increased signiﬁcantly in both
low-level and moderate-level GLE groups, whereas it decreased signiﬁcantly in high-level GLE rats with the high-intensity stimulus. (B) ERG a-wave amplitude at
10 msec increased signiﬁcantly in both low-level and moderate-level GLE groups compared with controls. (C) Relative to controls, peak ERG b-wave amplitude
increased signiﬁcantly in low-level and moderate-level GLE groups, whereas it decreased signiﬁcantly in high-level GLE rats with the high intensity stimulus. 
*p < 0.05, compared with corresponding controls.
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Figure 5. Histologic staining of adult control and GLE retinas with DAPI. Relative to controls, the thickness
of the ONL and INL nuclear layers appears to be increased in low-level and moderate-level GLE rats,
whereas the ONL thickness appears to be decreased in high-level GLE rats. Bar = 20 µm.
ONL
INL
ONL
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Control Low Pb
High Pb Moderate PbLeasure et al. 2007; Rice and Barone 2000;
Weiss et al. 2005). Second, low-level and
moderate-level GLE produced supernormal
scotopic ERGs in adult rats that are similar to
our ERG findings in male and female chil-
dren with GLE (Rothenberg et al. 2002).
Third, low-level and moderate-level GLE
increased neurogenesis of rod photoreceptors
and rod BCs without affecting Müller glial
cells. Fourth, GLE produced inverted
U-shaped dose–response curves, as the high-
level GLE produced subnormal ERGs and
rod cell loss. Fifth, GLE produced dose-
dependent decreases in adult retinal DA
synthesis and utilization/release.
One of our most important and clinically
relevant ﬁndings is that low-level and moder-
ate-level GLE produced supernormal ERGs in
adult rats. The BPb concentrations in these
two groups are similar to those measured in
pregnant women whose children had super-
normal ERGs (Rothenberg et al. 2002). In
contrast, high-level GLE produced subnormal
ERGs similar to those observed with PLE
(Fox and Farber 1988; Fox et al. 1991). These
ERG results are characteristic of inverted
U-shaped dose–response curves often observed
in Pb neurotoxicity studies (Davis and
Svendsgaard 1990; Leasure et al. 2007). These
ﬁndings show that scotopic ERG is a sensitive,
noninvasive biomarker that identiﬁed and dis-
criminated low-level and moderate-level GLE
from high-level GLE.
The GLE-induced increase in rods and
rod BCs likely explains the presence of super-
normal scotopic ERGs, as this would signiﬁ-
cantly amplify the rod signal. The molecular
mechanism responsible for this novel retinal
phenotype is unknown. Preliminary immuno-
histochemical data indicate that the increase
in rods and rod BCs is not due to a GLE-
induced decrease in apoptosis during devel-
opment. Thus, one attractive possibility is
that a developmental decrease in retinal DA
concentrations, similar to that observed in
adult GLE offspring, mediated this increased
neurogenesis. During early retinal develop-
ment, DA inﬂuences proliferation and differ-
entiation of progenitor cells by regulating the
rate of mitosis (Kralj-Hans et al. 2006).
Tyrosine hydroxylase–positive dopaminergic
amacrine cells appear before PND0 and dif-
ferentiate by PND14 (Wu and Cepko
1993)—the time period of GLE exposure
and when the majority of late-born rods
and BCs undergo terminal mitosis and differ-
entiation (Rapaport et al. 2004). Thus, a
decrease in retinal DA concentration during
development would increase progenitor cell
proliferation and produce more late-born
rods and rod BCs.
High-level GLE also decreased retinal DA
concentration. In contrast to the expected
increase in late-born neurons and supernormal
Gestational lead exposure and supernormal rod ERGs
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Figure 6. Morphometric and biochemical analysis of retinas from adult control and GLE rats. (A) Relative to
controls, the ONL, INL, and total retinal thickness increased signiﬁcantly in low-level and moderate-level GLE
rats, indicating an increased neurogenesis, whereas the ONL thickness signiﬁcantly decreased in high-level
GLE rats. (B) Compared with controls, the number of ONL rod nuclei and retinal rhodopsin levels increased
signiﬁcantly in low-level and moderate-level GLE rats, whereas these measures decreased signiﬁcantly in
high-level GLE rats. (C) PKCαβ immunoblots suggest that PKCαβ-positive rod BCs (top) increased signiﬁ-
cantly in low-level and moderate-level GLE rats relative to controls, which is consistent with the INL data in
(A); arrowheads indicate BC bodies. (D) Retinal GFAP was not affected by GLE exposure. 
*p < 0.05, compared with corresponding controls.
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GLE GLEERGs, high-level GLE offspring lost rods and
had subnormal ERGs. These findings are
similar to our retinal results with moderate-
level and high-level PLE (Fox and Chu 1988;
Fox and Farber 1988; Fox et al. 1991). Thus,
our results reveal dose-dependent and develop-
mental stage–dependent effects of Pb expo-
sure. Moreover, the findings of decreased
proliferation and/or neurogenesis in rat hippo-
campus after high-level GLE and/or PLE with
peak BPb concentrations ≥ 60 µg/dl (Gilbert
et al. 2005; Jaako-Movits et al. 2005; Verina
et al. 2007) are consistent with our results
and conclusions.
A second hypothesis suggests that low-to-
moderate decreases in DA metabolism result in
ERG supernormality, whereas larger decreases
produce ERG subnormality. Scotopic ERG
supernormality is a rare clinical finding; the
only other reported occurrence is in drug-
free patients with early Parkinson disease
(Terziivanov et al. 1983). In advanced stages
of Parkinson disease, the ERG is subnormal
(Gottlob et al. 1987; Ikeda et al. 1994). This
hypothesis is supported further by histologic,
neurochemical, and ERG dose–response stud-
ies with 6-hydroxydopamine (Olivier et al.
1986; Skrandies and Wässle 1988) and our
results. Together these ﬁndings indicate that
the ERG reversed from supernormal to sub-
normal when retinal DA concntrations
decreased > 40% and light-induced DA syn-
thesis or utilization/release decreased > 20%.
Although the mechanisms that underlie these
ERG changes are unknown, they may involve
the inhibitory effects of DA on rod Na+,K+-
ATPase activity (Shulman and Fox 1996).
Finally, decreases in retinal DA metabolism
increase the risk of spatiotemporal contrast sen-
sitivity deficits in adult humans and animals
(Bodis-Wollner 1990), as observed in monkeys
with lifetime Pb exposure (Rice 1998).
In summary, our results show that adult
GLE rats with previous BPb concentrations
of approximately 10 µg/dL, the current low-
level of concern [Centers for Disease Control
and Prevention (CDC) 1991], and approxi-
mately 20 µg/dL have persistent ERG super-
normality, increased rods and rod BC
neurogenesis, and decreased retinal DA synthe-
sis and utilization/release. The nonmonotonic
dose-dependent responses reveal that high-
level GLE produced opposite morphologic
and ERG effects. These data raise complex
issues for risk assessment and indicate that
dose-dependent and developmental stage-
dependent effects are important components
in risk assessment for neurotoxicity.
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Fox et al. [Environ Health Perspect
116:618–625 (2008) inadvertently used
the wrong calibration unit in the text
and Figure 3 of their article. Candela-
seconds per square meter (cd-sec/m2)
should have been Trolond-seconds
(td-sec) throughout.
The authors regret the error.